ReCognition Health
Re:Cognition Health is a private healthcare company focused on the diagnosis, treatment, and care of individuals with Alzheimer's disease, dementia, cognitive impairment, and other mental health conditions. Founded in 2011 by Dr. Emer MacSweeney and Tom Dent, the company operates a network of specialized clinics with six locations in the UK and four in the USA. These clinics are recognized centers for Alzheimer’s research, providing access to new-generation drugs and clinical studies aimed at modifying disease progression. The company offers comprehensive cognitive health assessments, diagnosis, treatment plans, and participation in clinical trials for emerging therapies. Re:Cognition Health emphasizes a multidisciplinary approach to ensure timely and accurate diagnosis and compassionate care. They provide Alzheimer’s medications such as Kisunla™ and Leqembi™ to eligible patients. The company serves individuals experiencing cognitive impairment, referring clinicians, employers, and investors, positioning itself as a trusted partner in advancing cognitive healthcare. Re:Cognition Health aims to lead in cognitive health by combining clinical excellence with innovative research.
Work at ReCognition Health in HR or recruiting? Claim this page
Headcount trend
ReCognition Health went from 14 employees in Jul 2023 to 22 in Jun 2025. Jan to Jun 2025: 2 people joined, 1 left.
Headcount data through Jun 2025
Org structure
Headcount by department
Peer reviews
Worked with someone at ReCognition Health?
Anonymous peer reviews on OffTheRecord
Similar companies
ReCognition Health FAQ
How many employees does ReCognition Health have?
ReCognition Health has about 22 employees, up 10% over the 3 months to Jun 2025.
What is ReCognition Health's revenue per employee?
ReCognition Health makes about $1M in revenue per employee, based on $22M annual revenue and 22 employees.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.